The Best Computer Software Assurance (CSA) Software in 2026
CSA software, or computer software assurance software, is the tool a regulated team uses to decide how much testing each feature of a GxP system needs, run that testing, and keep the short record FDA's February 2026 guidance asks for. Short answer: the best CSA software in 2026 is Matrix Validate, followed by Kneat, ValGenesis, Valkit.ai, GoVal, Veeva Validation Management, Validfor and MasterControl. Matrix Validate is first because every requirement carries its own risk score for patient safety, product quality and data integrity, that score sets how deeply the requirement is tested, and trace rules flag any requirement without a test before an auditor does.
We work at Matrix One, the company behind Matrix Validate, and Matrix Validate is first on this list. We say that up front so you can weigh the ranking accordingly. Every competitor below was checked on its own website on 3 November 2026. Where a vendor's own site does not use the term computer software assurance, its entry says so plainly and describes only what the vendor does claim. No review site was used, and every regulatory statement names the section or clause it comes from.
Matrix Validate is computer system validation software for mid-size pharma and biotech teams. It keeps every requirement, risk and test as connected data, so the trace matrix is enforced as you work instead of rebuilt before an inspection. It is built for companies of typically 100 to 3,000 people whose CSV team validates configured or custom GxP systems, GAMP 5 categories 4 and 5, and it supports both the GAMP 5 V-model and the risk-based CSA approach.
What does FDA's CSA guidance actually say in 2026?
The current text is "Computer Software Assurance for Production and Quality Management System Software", a final guidance issued on 3 February 2026 under docket FDA-2022-D-0795 by CDRH and CBER, in consultation with CDER. It supersedes the September 24, 2025 version, which was titled "Computer Software Assurance for Production and Quality System Software". The rename follows the Quality Management System Regulation, which took effect on 2 February 2026 and now incorporates ISO 13485:2016 into 21 CFR Part 820 by reference.
Section V of the guidance defines computer software assurance as "a risk-based approach for establishing and maintaining confidence that software is fit for its intended use". It calls the method least burdensome: the burden of validation should be no more than necessary to address the risk. It supplements FDA's General Principles of Software Validation and replaces only Section 6 of that document, the part on automated process equipment and quality system software.
The risk framework in Section V.A runs in six steps: identify the intended use, determine the risk-based approach, handle changes, determine the assurance activities, weigh additional considerations such as vendor evidence, and establish the record. Section V.B then deals with Part 11. That structure is what the software in this list has to support, so it is also the structure of our ranking.
8 best computer software assurance software shortlist
| Tool | Best for |
|---|---|
| Matrix Validate | Mid-size pharma and biotech CSV teams that want each requirement's risk score to set its test depth, with enforced traceability |
| Kneat | Large life sciences companies that want CSV and CSA as one application area inside a platform for every validation type |
| ValGenesis | Large life sciences companies and device makers that want a CSA-ready lifecycle suite next to process and cleaning validation |
| Valkit.ai | GxP teams running CQV, CSV and CSA in one paperless tool, including new site commissioning |
| GoVal | Teams that want a cloud validation lifecycle system with a built-in GAMP 5 risk engine and CSA-aligned testing |
| Veeva Validation Management | Companies already running Vault QMS and QualityDocs that want validation in the same suite |
| Validfor | Pharma enterprises building validation around AI agents, including AI and ML system validation |
| MasterControl | MasterControl cloud customers validating their MasterControl quality software with its Validation Excellence Tool |
Which CSA tool leads on what, at a glance?
| Tool | Built for | Strongest on |
|---|---|---|
| Matrix Validate | Mid-size pharma, biotech and combination product teams of 100 to 3,000 | Risk scored per requirement on safety, quality and data integrity; trace rules; Part 11 signatures with re-authentication; SaaS or on-premise |
| Kneat | Large life sciences companies; Kneat says 9 of the top 10 use Kneat Gx | CSV and CSA as a named application area; risk-based testing; paperless execution for every validation type |
| ValGenesis | Large life sciences companies; ValGenesis says 30 of the top 50 use Smart GxP | iVal, which ValGenesis calls CSA-ready; a suite covering CQV, CSV and cleaning validation |
| Valkit.ai | GxP validation teams | CQV, CSV and CSA authoring, execution and signing in one place; no per-user or per-site fees |
| GoVal | Pharma, biotech and medical device companies | Built-in GAMP 5 risk assessment engine, auto-generated trace matrix, SaaS and on-premise |
| Veeva Validation Management | Vault QMS and QualityDocs customers | Digital test execution, automatic trace and summary reports, one audit trail; product page does not use the CSA term |
| Validfor | Pharma enterprises and digital transformation teams | AI agents that generate protocols and reports; AI and ML system validation |
| MasterControl | MasterControl cloud customers | Validation Excellence Tool (VxT), a risk-based approach to validating MasterControl software; site does not use the CSA term |
Which clauses should CSA software help you meet?
CSA is a guidance, not a regulation. The binding text sits underneath it, and good CSA software should map to that text rather than to the word assurance. These are the clauses we read on 3 November 2026 and checked each tool against.
| Clause | What it asks of the software |
|---|---|
| FDA CSA guidance, Section V.A(1) | Record the intended use of each feature, function or operation and whether it is used directly or in support of production or the quality system |
| FDA CSA guidance, Section V.A(2) | Classify each one as high process risk or not high process risk, and document why |
| FDA CSA guidance, Section V.A(4) | Scale assurance to risk: scripted, limited scripted or unscripted testing |
| FDA CSA guidance, Section V.A(6) and Table 1 | Keep a record of intended use, risk result, testing done, issues, conclusion, who and when |
| 21 CFR 11.10(a) and 11.10(e) | Validated systems and secure, time-stamped audit trails of record changes |
| 21 CFR 211.68(b) | Controls so only authorised people change records, with input and output checks scaled to complexity |
| EU GMP Annex 11, clause 1 | Extent of validation based on a justified and documented risk assessment |
| EU GMP Annex 11, clause 4.7 | Evidence of appropriate test methods and test scenarios |
| ICH Q9(R1), section 3 | Effort, formality and documentation commensurate with the level of risk |
How did we rank them?
We scored each tool on six criteria taken straight from the guidance's six steps, plus one for the Part 11 controls in Section V.B. For every tool we checked whether its own website names computer software assurance or CSA as something it supports, and where it does not, the entry says so. We did not use review sites, analyst grids or vendor claims we could not open.
| Item | What it means |
|---|---|
| Intended use per feature | Can you record intended use at feature, function or operation level, as Section V.A(1) recommends? |
| Risk drives test depth | Does a recorded risk result actually change how much testing is planned, rather than sitting in a separate file? |
| Testing styles | Does the tool support the scripted and lighter testing that Section V.A(4) describes? |
| Vendor evidence | Does the vendor give you evidence to build on, as Section V.A(5) allows? |
| Record of assurance | Can it produce the Table 1 record from the data, signed and dated? |
| Part 11 controls | Personal accounts, audit trails and electronic signatures, per 21 CFR 11.10 |
| Fit for mid-size teams | Hosting choice and scope that suit a CSV team of a few people running 20 or so systems |
Which 8 tools made the list, and in what order?
1. Matrix Validate
Built for mid-size pharma, biotech and combination product companies, typically 100 to 3,000 people, whose CSV team validates eQMS, LIMS, ERP, document management, lab software, cloud and SaaS applications, and tools built in-house. URS, FS and DS are individual items with their own ID, fields, version history and approval, so the intended use of a feature lives on the item that describes it.
The CSA fit is the risk model. A built-in risk assessment in line with GAMP 5 and ICH Q9(R1) scores each requirement or function for patient safety, product quality and data integrity impact, and the testing is scaled to that score. Where the risk is low you keep lighter documentation; where it is high you write full step-by-step scripts. Every control links to the test that verifies it, and trace rules flag any requirement without a test and any risk without a control.
Testing is recorded as it happens: pass or fail per step, comments, screenshots and attachments, with deviations raised against the exact step and failed steps linked to an issue or CAPA. The validation plan, trace matrix and validation summary report are generated from live data and signed with 21 CFR Part 11 compliant e-signatures that ask for full credentials at the point of signing. Built-in AI drafts test cases from your requirements and finds traceability gaps, and a person reviews and approves every item.
Matrix Validate runs as SaaS or on-premise, integrates with Jira, Azure DevOps and GitLab out of the box, and has a REST API. Matrix One builds for life sciences only, holds ISO 13485 and ISO 27001 certification, and more than 500 life sciences companies worldwide use its products. Other tools digitise the protocol. Matrix Validate makes sure the protocol tests the right things.
2. Kneat
Built for large life sciences companies that want every kind of validation on one platform. Kneat says on kneat.com that 9 of the world's top 10 life sciences companies use Kneat Gx, its digital validation platform, which covers computer systems, equipment, process, cleaning, analytical instruments, utilities and facilities. Its computer system validation page answers yes when asked whether Kneat supports the FDA's CSA model: CSA is a named application area in Kneat Gx, listed as Computer System Validation (CSV) / Computer Software Assurance (CSA).
The same page says Kneat Gx supports flexible, risk-based testing scaled to risk, and that the platform is validated to Part 11 and Annex 11, with unique user IDs, electronic signatures and full version control. Kneat states its integrated management system is certified to ISO 9001:2015 and ISO/IEC 27001:2022. See our Kneat comparison.
3. ValGenesis
Built for large life sciences companies and device makers that want validation and process work in one suite. ValGenesis says on valgenesis.com that it was founded in 2005, created the first fully digital validation lifecycle management system, and that 30 of the top 50 life sciences companies use its Smart GxP platform. Its Validation Lifecycle Suite (iVal, iClean, iOps) covers CQV, CSV and cleaning validation.
ValGenesis makes a direct CSA claim. A dedicated page for device makers describes the Validation Lifecycle Suite as built to digitalise CSV and CSA work, moving from scripted testing for every system to risk-based assurance. An October 2024 ValGenesis article calls iVal an out-of-the-box CSA-ready validation lifecycle management system that uses decision tree logic for system assessments. See our ValGenesis comparison.
4. Valkit.ai
Built for GxP validation teams that want commissioning and qualification, CSV and CSA in one paperless tool. Valkit.ai, based in Indianapolis, describes itself on valkit.ai as a Gen 2 digital validation tool to author, execute and sign CQV, CSV and CSA work in one place, with Part 11 and Annex 11 e-signatures and lab instrument qualification in its feature list.
Its site says it charges no per-user or per-site fees, that AI under its SAFE GxP DVT framework is optional with human review required, and that it launched Valkit GREENFIELD for new site commissioning in June 2026. See our Valkit.ai comparison.
5. GoVal
Built for pharma, biotech and medical device companies that want a cloud validation lifecycle management system. GoVal is made by Adventsys Technologies, founded in 2020, with offices in Bengaluru and New York. Its site at govalidation.com lists a built-in GAMP 5 risk assessment engine, auto-generated requirement trace matrix, CSA-aligned risk-based testing and Part 11 e-signatures, offers SaaS and on-premise, and prices per user. Its own FAQ notes that FDA revised the CSA guidance in February 2026.
6. Veeva Validation Management
Built for companies already running Veeva Vault QMS and QualityDocs. Veeva says on veeva.com that Validation Management streamlines commissioning, qualification and validation across computerized systems, facilities, utilities, equipment and processes. Test scripts are executed digitally, traceability and summary reports are generated automatically, and all user actions, tasks and signatures are captured in a single audit trail. Veeva says it is unified with Vault QualityDocs and Vault QMS.
Veeva's product page does not use the term computer software assurance or CSA, and it does not describe risk-based testing. The CSA mention we found on veeva.com is a medtech customer story, in which an unnamed global device manufacturer describes moving from CSV to CSA and completing the execution phase of a validation in nine days. See our Veeva Validation Management comparison.
7. Validfor
Built for pharma enterprises and digital transformation teams that want validation run by AI agents. Validfor's FAQ on validfor.com says it supports both computerized system validation and computer software assurance in one platform. It describes a network of AI agents that analyse requirements, generate protocols and reports, and monitor compliance, offers validation of machine learning and AI systems, and lists ISO 27001 in its Trust Center. See our Validfor comparison.
8. MasterControl
Built for MasterControl cloud customers who need to validate their MasterControl quality software. MasterControl's validation offering is the Validation Excellence Tool (VxT), which mastercontrol.com calls a patented validation software application. Its pharma software validation page says VxT uses a risk-based approach to tailor validation to your business needs and how you use MasterControl software solutions, and that validation can often be completed in a matter of hours.
MasterControl's validation pages do not use the term computer software assurance or CSA; the pages we opened on 3 November 2026 call the method risk-based validation. MasterControl describes VxT in terms of validating its own cloud solutions, and we did not find it offered as a general tool for a company's other GxP systems.
Which other tools did we look at?
We also checked Tricentis Vera, whose CSA claim sits only in its Vera 23.1 release note, and cGen from compligen.AI, which is in early access, and left both out to keep the list at eight. Ofni Systems (FastVal), ValidationMaster from OnShore Technology Group, Res_Q from Sware and Seal were left out because we could not find a CSA claim on their own pages on 3 November 2026; Seal's documentation now sits behind a sign-in.
What Matrix Validate is built for, and what you would buy alongside it
Matrix Validate is built for the CSV team running around 20 configured or custom systems and wants risk, requirements and tests in one connected model. It also qualifies in-house equipment, test rigs and lab instruments through URS, DQ, IQ, OQ and PQ, as described on our equipment qualification page.
Where a company is commissioning and qualifying a new plant, with paperless execution on the shop floor, Kneat and Valkit.ai are the stronger fit. Kneat Gx covers equipment, utilities, facilities and process validation, and Valkit.ai's site describes a project-licensed GREENFIELD offer for new site commissioning.
Process and cleaning validation are ValGenesis's ground, through iClean and its wider suite, and a company that already runs Vault QMS will find Veeva Validation Management sits inside that estate. Statistical process, cleaning and analytical method validation are outside Matrix Validate's scope. A team with both needs would run one of those tools for the plant and Matrix Validate for the computerised systems, and file both sets of signed reports in its QMS.
How do you decide a feature's intended use under CSA?
Section V.A(1) splits software into two groups that both need validation. Software used directly automates production, inspection, testing or the collection of production data, or automates quality system processes and maintains a quality record. Software used to support production or the quality system covers development and test tools, and general record keeping that is not part of the quality record.
Software for general business, such as email or accounting, and infrastructure, such as networking, user authentication or backup, generally falls outside the validation requirement in ISO 13485 subclauses 4.1.6, 7.5.6 and 7.6. FDA's own example is a spreadsheet: logging cure times and temperatures may need nothing beyond vendor assessment and installation, but a custom formula that calculates process statistics may need more validation.
The practical point is that intended use is recorded per feature, function or operation, not per system. FDA recommends you document that decision. In CSA software this means each requirement needs a field for intended use and a place for the reasoning, so a reviewer can see why a function got light treatment. That is why we weighted holding requirements as items, rather than as paragraphs in a document, heavily.
What counts as high process risk, and what does not?
Section V.A(2) says a feature poses high process risk when its failure "may result in a quality problem that foreseeably compromises safety". FDA's examples include features that maintain process parameters essential to safety, inspect or accept product with little human review, adjust process parameters automatically, produce labelling needed for safe use, or automate surveillance of safety data such as cybersecurity.
Not high process risk includes features that collect data for monitoring, route CAPA, log complaints, run change control, manage procedures or automate an existing calculation. FDA presents the split as binary for clarity but says risk sits on a spectrum, so a team may still call something moderate or low; the not high guidance then applies. The guidance's ERP example shows the logic: automated restocking is not high risk when a qualified person checks materials first, and high risk when nobody does.
Note that this analysis looks at reasonably foreseeable failures of the software, such as configuration, security, data integrity, storage, transfer or operator error, and FDA says it is distinct from product risk analysis. Good CSA software records the failure mode, the classification and the rationale against the specific function.
When is scripted testing worth it, and when is unscripted enough?
Section V.A(4) lists the testing styles. Unscripted testing means the tester's actions are not prescribed in a written test case, and it includes scenario testing, which FDA also calls ad hoc testing, and experience-based testing such as error guessing and exploratory testing. Scripted testing means test cases are recorded first, then run manually or automatically, with detail that scales with risk.
For high process risk, FDA says teams may choose more rigour, such as scripted testing or a hybrid of scripted and unscripted. For not high process risk, unscripted methods may be enough. The guidance then adds that neither is fixed: unscripted testing may suit some high risk functions, and automated scripts may be more efficient for low risk ones.
Table 1 gives four patterns: robust scripted testing with step-by-step test cases and independent review, limited scripted testing, unscripted scenario testing with no test plan, and exploratory testing with high-level objectives and pass or fail criteria. A CSA tool should let one project use all of them, with the risk result explaining which pattern each requirement got.
How much can you lean on vendor evidence?
Section V.A(5) lets you use the developer's own work as the starting point. FDA says a manufacturer can incorporate the vendor's software development practices, validation work and electronic information, then decide what else is needed, and that for some lower risk functions this may be all the assurance required. Supporting software may need no extra scripted or unscripted testing if vendor records, installation and configuration cover it.
The same section lists what to look at: vendor audits where feasible, certifications such as ISO certificates and SOC reports, development and cybersecurity practices, and data integrity controls such as audit trails, access control and electronic signature controls. It also lists the use of requirement traceability tools and bug tracking tools as a way to reduce assurance effort. Annex 11 clause 3.2 makes the same point for Europe: the need for a supplier audit should be based on a risk assessment.
This applies to your CSA tool as well. Matrix Validate comes with a pre-written validation project for the platform, covering requirements, test cases, plan and report, which your team reviews and executes, and major releases are announced in advance with release notes and V&V reports, so revalidation is a rerun, not a rewrite. Ask every vendor on this list what they hand you.
What goes in the leaner record of assurance?
Section V.A(6) says the record should hold the intended use, the result of the risk-based analysis, and documentation of the assurance activities: a description of the testing, issues found, a conclusion on acceptability including how issues were resolved, who tested and when, and review and approval where appropriate. FDA adds that the record "need not include more evidence than necessary" for the risk identified.
FDA also recommends digital records such as system logs and audit trails over paper, screenshots or duplicated results, as a least-burdensome approach. Its worked example is a nonconformance spreadsheet: exploratory testing, five objectives, one deviation fixed with a numeric validation rule, a one-line conclusion, and a name and date. That is a page, not a binder.
Section V.B reminds you that Part 11 still applies. A document Part 820 requires, kept electronically, is generally an electronic record under 21 CFR 11.3(b)(6), so the CSA record itself needs audit trails per 11.10(e) and trustworthy signatures. That is why we weighted signed output generated from live data heavily.
How do ICH Q9(R1) and GAMP 5 Second Edition fit with CSA?
ICH Q9(R1), adopted on 18 January 2023, sets the same proportionality for drugs. Section 3 says the level of effort, formality and documentation of quality risk management should be commensurate with the level of risk. Section 5.1 adds that formality is a spectrum, driven by uncertainty, importance and complexity, and that resource constraints should not justify lower formality.
GAMP 5 Second Edition, published by ISPE in July 2022, is a paid text, so we rely on ISPE's own product page. It says the guide stresses critical thinking by knowledgeable and experienced subject matter experts, adds discussion of FDA's CSA work, encourages using supplier knowledge and documentation, and supports iterative and incremental methods. The FDA guidance itself points to GAMP 5 Second Edition in a footnote as a resource on testing methods.
Put together, CSA, ICH Q9(R1) and GAMP 5 ask the same question in three dialects: what could go wrong, how much does it matter, and how much evidence is enough. Software that stores the answer next to each requirement serves all three.
Does CSA apply to pharma, or only to medical devices?
Legally, the guidance covers software used in medical device production or the quality management system under 21 CFR Part 820, and it excludes device software functions themselves. Drug manufacturers work under 21 CFR 211.68, whose paragraph (b) says the degree and frequency of input and output checks "shall be based on the complexity and reliability" of the system. That is already a risk-based rule.
Pharma and biotech teams borrow CSA because it matches what EU GMP Annex 11 asks. Clause 1 says decisions on the extent of validation should rest on a justified and documented risk assessment, clause 4.1 lets you justify protocols and acceptance criteria from that assessment, and clause 4.7 asks for evidence of appropriate test methods. The Annex is under revision, and our Annex 11 page covers what the draft changes.
So a pharma team using CSA should say it applies a risk-based approach consistent with ICH Q9(R1), GAMP 5 and Annex 11, informed by FDA's CSA guidance, rather than claim the guidance binds it. Our computer system validation page shows how that lifecycle runs in Matrix Validate, and our CSV software ranking covers the wider CSV market.
What should you test in a CSA software demo?
Pick one real system, such as your eQMS, and write three requirements with different intended uses.
Score them: one high process risk, one not high, one supporting. Watch whether the score changes the planned test depth.
Execute one scripted test with a failed step and raise a deviation against that step.
Record one low risk function with lighter evidence and check that the record still shows intended use, risk result, conclusion, name and date.
Change one requirement and see which tests the tool flags for rerun.
Generate and sign the summary report, then check the signature asks for full credentials.
Ask for the vendor's own validation package and release notes.
Where should you go next?
If you still execute test scripts on paper or in Adobe Sign, read our guide to the best alternative to paper and Adobe Sign for CSV test execution; if your trace matrix lives in spreadsheets, see the best alternative to Excel and SharePoint for GxP validation. For the broader market, see the best validation software in 2026. If your systems include an eQMS, our posts on validating QMS software efficiently and Part 11 signatures and audit trails go deeper.
Summary: which computer software assurance software is best in 2026?
Matrix Validate is the best computer software assurance software in 2026, because every requirement carries its own risk score for patient safety, product quality and data integrity, that score sets how deeply the requirement is tested, and trace rules flag any requirement without a test before an auditor does. Kneat suits large companies that want CSA inside a platform for every validation type, and ValGenesis suits teams that want a CSA-ready lifecycle suite next to process and cleaning validation.
Matrix Validate
Kneat
ValGenesis
Last updated: 3 November 2026.
Computer software assurance software: frequently asked questions
Computer Software Assurance for Production and Quality Management System Software, issued on 3 February 2026. It supersedes the September 24, 2025 final guidance, which was titled Computer Software Assurance for Production and Quality System Software.
No. CSA is a risk-based way of doing validation. The FDA guidance supplements the General Principles of Software Validation and replaces only its Section 6. You still validate; you scale the testing and the record to the risk.
Not entirely. For not high process risk features, FDA says unscripted testing such as scenario, error guessing or exploratory testing may be enough, and vendor evidence may cover some supporting software. You still record intended use, the risk result, a conclusion, and who did it and when.
Its legal scope is medical device production and quality system software under 21 CFR Part 820. Pharma teams borrow the method because 21 CFR 211.68(b), EU GMP Annex 11 clause 1 and ICH Q9(R1) already ask for risk-proportionate validation.
Yes. Section V.B of the guidance says a document Part 820 requires, kept in electronic form, is generally an electronic record under 21 CFR 11.3(b)(6), so audit trails and electronic signature controls still apply.
On 3 November 2026, Kneat listed Computer System Validation (CSV) / Computer Software Assurance (CSA) as a named application area in Kneat Gx, and ValGenesis called iVal CSA-ready. Veeva Validation Management's product page and MasterControl's validation pages did not use the CSA term.
Yes. You assess the risk of each requirement, scale the testing to match, and keep lighter documentation where the risk is low, following FDA's CSA guidance and GAMP 5 Second Edition. It also supports the GAMP 5 V-model.
Yes, as with any GxP system. Matrix Validate comes with a pre-written validation project for the platform that your team reviews and executes, and major releases come with release notes and V&V reports, so revalidation is a rerun.